Pharmaceuticals Sector Actividad de insiders

Sigue las compras y ventas de insiders en acciones de Healthcare. Descubre qué ejecutivos compran, la actividad neta de insiders y el % del capital flotante negociado en 752 empresas.
La información que se muestra en esta pantalla tiene fines meramente informativos y no constituye asesoramiento financiero. No recomendamos ninguna inversión específica basándonos en estos criterios.
Empresas
Datos
Suscríbase para acceder a todos los datos.
Compañía Grupo industrial Capitalización de mercado ($) # Compras netas de insiders Valor neto de la compra ($) % de flotación comprada % de acciones en manos de insiders
Pharmaceuticals Mega (1.1tn) 0 No hay actividad — 0–15%
Pharmaceuticals Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (371.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (313.6bn) 0 No hay actividad — —
CH Novartis AG (NOVN)
Pharmaceuticals Mega (298.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (247.3bn) 0 No hay actividad — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (237.5bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 No hay actividad — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (159.4bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (137.4bn) -1–5 -< $100K -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (104.9bn) 0 No hay actividad — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (101.1bn) 11–20 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 No hay actividad — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 No hay actividad — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 No hay actividad — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 1–5 $1M–$10M 0–15% —
BE Ucb SA (UCB)
Pharmaceuticals Large (49.4bn) 1–5 $100K–$1M 0–15% 15–50%
GB Haleon PLC (HLN)
Pharmaceuticals Large (41.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (39.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (33.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (32.0bn) 0 No hay actividad — 50%+
US Biogen Inc (BIIB)
Pharmaceuticals Large (31.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals Large (30.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (26.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (25.2bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals Large (19.4bn) 0 No hay actividad — 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (18.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (16.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 No hay actividad — 15–50%
Pharmaceuticals Large (15.6bn) 0 No hay actividad — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (15.4bn) 0 No hay actividad — 50%+
Pharmaceuticals Large (13.4bn) 0 No hay actividad — 50%+
Pharmaceuticals Large (13.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (13.3bn) -1–5 -$1M–$10M -0–15% 0–15%
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (12.9bn) 0 No hay actividad — 50%+
Pharmaceuticals Large (12.7bn) 0 No hay actividad — 15–50%
Pharmaceuticals Large (12.4bn) 0 No hay actividad — 50%+
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (11.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Mid (8.8bn) -6–10 -$1M–$10M -0–15% 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 No hay actividad — 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals Mid (7.4bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (7.1bn) 0 No hay actividad — 0–15%
ES Grifols SA (GRF)
Pharmaceuticals Mid (7.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals Mid (7.1bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (7.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (6.8bn) 0 No hay actividad — 50%+
US Medicines Co (MDCO)
Pharmaceuticals Mid (6.8bn) 0 No hay actividad — —
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals Mid (6.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (6.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals Mid (5.3bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (5.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (5.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals Mid (5.0bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (5.0bn) -1–5 -< $100K -0–15% 50%+
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals Mid (4.8bn) -1–5 -$100M+ -0–15% 50%+
Pharmaceuticals Mid (4.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (4.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (4.6bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals Mid (4.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals Mid (4.3bn) 0 No hay actividad — 0–15%
GB Indivior PLC (INDV)
Pharmaceuticals Mid (4.2bn) 1–5 $100K–$1M 0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals Mid (4.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (4.1bn) -1–5 -< $100K -0–15% 15–50%
SE Camurus AB (CAMX)
Pharmaceuticals Mid (3.8bn) -1–5 -$100K–$1M -0–15% 15–50%
US Perrigo Co (PRGO)
Pharmaceuticals Mid (3.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (3.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (3.7bn) 0 No hay actividad — 15–50%
US Organon & Co (OGN)
Pharmaceuticals Mid (3.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (3.5bn) 0 No hay actividad — 50%+
FR Virbac SA (VIRP)
Pharmaceuticals Mid (3.2bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (3.2bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (3.2bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (2.9bn) 0 No hay actividad — 0–15%
ES Almirall SA (ALM)
Pharmaceuticals Mid (2.9bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (2.9bn) 0 No hay actividad — 15–50%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals Mid (2.8bn) 0 No hay actividad — 15–50%
Pharmaceuticals Mid (2.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.7bn) 0 No hay actividad — —
Pharmaceuticals Mid (2.7bn) 0 No hay actividad — 0–15%
US Zai Lab Ltd (9688)
Pharmaceuticals Mid (2.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (2.5bn) 0 No hay actividad — 15–50%
Pharmaceuticals Mid (2.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mid (2.5bn) -1–5 -$100K–$1M -0–15% 15–50%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals Mid (2.5bn) 0 No hay actividad — 50%+
Pharmaceuticals Mid (2.4bn) 0 No hay actividad — 0–15%
US Vericel Corp (VCEL)
Pharmaceuticals Mid (2.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.3bn) 0 No hay actividad — 15–50%
Pharmaceuticals Mid (2.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.2bn) 0 No hay actividad — 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals Mid (2.2bn) 0 No hay actividad — 50%+
BE Fagron NV (FAGR)
Pharmaceuticals Mid (2.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals Mid (2.0bn) 0 No hay actividad — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals Mid (2.0bn) 0 No hay actividad — 50%+
Pharmaceuticals Small (1.7bn) 0 No hay actividad — 0–15%